Comprehensive medication guide to Tri-Lo-Sprintec 28 Day including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0 copay for most commercial insurance plans under the ACA contraceptive mandate; Tier 1–2 generic on most formularies; Medicaid covers at $0 or minimal copay in most states.
Estimated Cash Pricing
$100–$126 retail for generic per 28-day pack; as low as $22.20 with GoodRx or $8.93 with SingleCare coupons at most major pharmacies.
Medfinder Findability Score
82/100
Summarize with AI
On this page
Tri-Lo-Sprintec 28 Day (norgestimate/ethinyl estradiol) is a combination oral contraceptive (COC) pill that contains two synthetic hormones: norgestimate (a progestin) and ethinyl estradiol (an estrogen). It is a triphasic, low-dose formulation, meaning the norgestimate dose changes across three phases of the 28-day cycle while the estrogen dose (25 mcg ethinyl estradiol) remains constant at a lower level than many other combination pills.
Tri-Lo-Sprintec is a generic medication manufactured by Teva Pharmaceuticals and is the generic equivalent of the discontinued brand-name Ortho Tri-Cyclen Lo. The medication was initially approved by the FDA in 1989 (original brand) and remains widely available in multiple generic forms including Tri-Lo-Estarylla, Tri-Lo-Mili, Tri-Lo-Marzia, and Tri-Vylibra Lo.
Each 28-day blister pack contains 21 active hormone tablets in three color-coded phases (gray, light blue, and blue), followed by 7 white inert/placebo tablets. One tablet is taken by mouth daily at the same time each day for 28 consecutive days, then a new pack is started immediately.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Tri-Lo-Sprintec prevents pregnancy primarily by suppressing ovulation. The combination of norgestimate and ethinyl estradiol inhibits the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland — the hormonal signals that normally trigger the release of an egg from the ovary. Without ovulation, fertilization cannot occur.
As a secondary mechanism, the progestin norgestimate thickens the cervical mucus, making it harder for sperm to travel through the cervix toward the uterus. It also alters the endometrial lining of the uterus, making it less receptive to implantation. These backup mechanisms provide additional contraceptive protection even if ovulation suppression is incomplete.
The triphasic dosing design — with norgestimate increasing from 0.18 mg to 0.215 mg to 0.25 mg across three phases — mimics the natural hormonal fluctuation of the menstrual cycle, allowing effective contraception with lower average hormone exposure compared to monophasic formulations.
0.18 mg / 0.025 mg — tablet (gray, phase 1)
7 gray tablets — norgestimate 0.18 mg + ethinyl estradiol 0.025 mg (days 1–7)
0.215 mg / 0.025 mg — tablet (light blue, phase 2)
7 light blue tablets — norgestimate 0.215 mg + ethinyl estradiol 0.025 mg (days 8–14)
0.25 mg / 0.025 mg — tablet (blue, phase 3)
7 blue tablets — norgestimate 0.25 mg + ethinyl estradiol 0.025 mg (days 15–21)
inert — tablet (white, placebo)
7 white inert tablets — no active ingredients (days 22–28); withdrawal bleed typically occurs during this phase
As of 2026, Tri-Lo-Sprintec 28 Day is not listed on the FDA's official drug shortage database. National supply from multiple generic manufacturers is generally stable. However, individual pharmacies may periodically run out of their preferred brand due to ordering schedules or distribution lags. The most common reason patients struggle to find it is that a pharmacy carries only one brand (e.g., Tri-Lo-Sprintec) and it is temporarily out of stock, while equivalent generics (Tri-Lo-Estarylla, Tri-Lo-Mili, Tri-Lo-Marzia) are available nearby.
If your pharmacy is out of stock, medfinder can help you find which pharmacies near you have Tri-Lo-Sprintec or an equivalent generic in stock — without spending hours on hold.
Patients can also significantly improve access by asking their prescriber to write for the generic name (norgestimate/ethinyl estradiol triphasic, low dose) without a 'dispense as written' restriction, and requesting a 90-day supply through a mail-order pharmacy, which maintains large inventories and rarely faces stockouts.
Tri-Lo-Sprintec is not a controlled substance, so no special DEA licensing is required beyond a standard prescribing license. Any licensed prescriber authorized to write prescriptions in their state can prescribe Tri-Lo-Sprintec.
Telehealth services such as Nurx, The Pill Club, Pandia Health, and Hims & Hers can also prescribe and ship Tri-Lo-Sprintec or equivalent generics directly to patients after an online consultation. This is often the fastest route to a prescription, with same-day or next-day prescription issuance.
No. Tri-Lo-Sprintec 28 Day (norgestimate/ethinyl estradiol) is not a controlled substance and is not scheduled by the DEA. It is a standard prescription medication that can be prescribed by any licensed healthcare provider, including physicians, nurse practitioners, and physician assistants.
Because it is not a controlled substance, there are no restrictions on the number of refills or the quantity that can be prescribed. Prescribers can write for a 90-day supply (3 packs), which is common practice for oral contraceptives. Prescriptions can also be filled through mail-order pharmacies without any additional DEA-related requirements.
Most common side effects (typically improve within 1–3 months):
Serious side effects — seek immediate medical attention:
Know what you need? Skip the search.
Tri-Lo-Estarylla 28 Day
FDA AB-rated equivalent to Tri-Lo-Sprintec; identical active ingredients (norgestimate/ethinyl estradiol triphasic low-dose); therapeutically interchangeable
Tri-Lo-Mili 28 Day
FDA AB-rated equivalent; same norgestimate/EE triphasic low-dose regimen; often cheaper at certain pharmacies
Tri-Sprintec 28 Day
Same norgestimate doses but higher estrogen (35 mcg EE vs. 25 mcg); requires new prescription; consider for patients without estrogen sensitivity
Sprintec 28 Day
Monophasic norgestimate/EE (0.25 mg / 0.035 mg); same active ingredients in fixed dose; simplest therapeutic switch if triphasic specifically not required
Prefer Tri-Lo-Sprintec 28 Day? We can find it.
Rifampin (rifampicin)
majorStrongly induces CYP3A4; significantly reduces COC blood levels and contraceptive effectiveness. Use backup contraception and continue for 28 days after stopping rifampin.
Ombitasvir/paritaprevir/ritonavir (Viekira Pak / Technivie)
majorContraindicated. Combination HCV drugs cause ALT elevations >5x ULN when used with estrogen-containing COCs.
St. John's Wort (Hypericum perforatum)
majorStrong CYP3A4 inducer. Can significantly reduce COC effectiveness. Avoid use with Tri-Lo-Sprintec.
Phenytoin (Dilantin)
moderateAnti-seizure medication; CYP3A4 inducer; reduces COC plasma concentrations. Use backup contraception.
Carbamazepine (Tegretol)
moderateAnti-seizure / mood stabilizer; CYP3A4 inducer; reduces COC effectiveness. Use backup contraception.
Topiramate (Topamax)
moderateAnti-seizure / migraine medication; CYP3A4 inducer; may reduce COC effectiveness. Use backup contraception.
Lamotrigine (Lamictal)
moderateEstrogen-containing COCs may significantly decrease lamotrigine plasma levels, potentially reducing seizure control. Requires close monitoring.
Cyclosporine
moderateCOCs may increase cyclosporine blood levels. Monitor closely for cyclosporine toxicity.
Phenobarbital
moderateBarbiturate; CYP3A4 inducer; reduces COC effectiveness. Use backup contraception.
Rifabutin
moderateRelated to rifampin; CYP3A4 inducer; reduces COC effectiveness. Use backup contraception.
Tri-Lo-Sprintec 28 Day is a well-established, widely available combination oral contraceptive with a strong safety and efficacy record. Its low-dose estrogen (25 mcg) makes it suitable for many patients who experience estrogen-related side effects with higher-dose formulations. With multiple FDA AB-rated generics on the market and stable national supply, most patients have access to this medication or an equivalent at low or no cost.
Access issues, when they occur, are typically pharmacy-level logistics rather than true national shortages. The most effective solutions are asking for equivalent generics at the pharmacy, requesting a generic prescription without DAW restrictions from your provider, and using mail-order pharmacy for 90-day supplies.
If you're having trouble finding Tri-Lo-Sprintec in stock, medfinder can do the pharmacy searching for you — calling nearby pharmacies and texting you which ones have it in stock.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards